MedTrace Logo

Prognostic Value of Flow-mediated Dilation in Hospitalized COVID-19 Patients

NCT04714125 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2021-01-19

No results posted yet for this study

Summary

This study will evaluate the associations between vascular parameters and clinical outcomes in patients hospitalized with COVID-19.

The vascular function and structure of individuals with COVID-19 admitted to the General Hospital of the University of Sao Paulo will be assessed in the first 72 hours of hospitalization. Then, participants will be followed up until hospital discharge/death.

Logistical regressions will be run to evaluate if vascular function/structure can predict ICU admissions, intubation, thrombosis or death.

Conditions

  • Covid19
  • SARS-CoV Infection

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-19
Primary Completion
2021-02-01
Completion
2022-06-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04714125 on ClinicalTrials.gov